Chesapeake Oncology Hematology Associates in Baltimore: Medical Oncology with Infusion Services

Chesapeake Oncology Hematology Associates is a standalone medical oncology and hematology practice located in Baltimore that provides outpatient cancer treatment, including chemotherapy and targeted therapy infusions, alongside diagnostic and follow-up care for blood disorders. Unlike larger hospital-based oncology programs, this practice operates as a specialized independent group focused on direct patient management rather than emergency or inpatient services.

What the practice actually does

The group treats solid tumors (lung, breast, colorectal, gastric, pancreatic, and others) and hematologic malignancies, including lymphoma and leukemia. Services include initial consultations with board-certified medical oncologists, staging and treatment planning, chemotherapy and immunotherapy administration in an on-site infusion center, supportive care (antiemetics, hydration, transfusions), and ongoing surveillance for patients in remission. The practice does not perform bone marrow biopsies or aspirations in-house; those procedures are referred to a hospital laboratory partner. Patients requiring surgery or radiation are referred to appropriate specialists, making this a consultation-and-infusion-centered model rather than a comprehensive cancer center.

Services and infusion logistics

Initial consultation visits typically run 60 to 90 minutes and include history, physical examination, review of prior pathology and imaging, and a written treatment plan. Follow-up visits during active treatment are 30 to 45 minutes. Chemotherapy and immunotherapy infusions are administered in a dedicated infusion suite; most sessions last 1 to 6 hours depending on the regimen. The practice manages side effects with supportive medications and nursing observation. Specific pricing for consultations and infusions is not publicly listed; costs are insurance-dependent and require direct inquiry. Patients should verify their insurance acceptance and authorization requirements before scheduling (call to confirm current accepted plans and any recent changes).

The infusion center operates weekday business hours; Saturday infusions are not offered. Patients receiving active chemotherapy are typically scheduled every 2 to 4 weeks, depending on their cycle, so treatment planning should account for consistent availability.

How Chesapeake Oncology compares to Baltimore-area oncology options

Baltimore has access to NCI-designated comprehensive cancer centers (Johns Hopkins Kimmel Cancer Center and University of Maryland Medical Center) as well as community oncology practices. Johns Hopkins and University of Maryland offer multi-disciplinary tumor boards, on-site surgery and radiation, clinical trials, and advanced molecular profiling; these are appropriate for newly diagnosed patients with complex disease or enrollment in research protocols. Chesapeake Oncology is better suited to patients already established on a treatment plan or those seeking continuity of care with a single physician outside a hospital system. Independent practices often have shorter appointment lead times (sometimes same-week) and may allow longer consultation times than hospital clinics, though this varies week to week.

Patients with metastatic disease or rare cancers may benefit from the tumor boards and genetic testing capabilities at academic centers; those with common, early-stage malignancies or receiving established chemotherapy regimens may find equivalent care at Chesapeake Oncology with less system-level scheduling friction.

Who this practice suits and does not suit

Chesapeake Oncology is a fit for patients with confirmed cancer diagnoses already under care elsewhere who want to transfer to a smaller practice for closer relationship with their oncologist, for patients requiring long-term follow-up after completing treatment at a hospital, and for those with hematologic disorders (lymphoma, leukemia, plasma cell disorders) who prefer outpatient-focused management. It suits patients with insurance that covers out-of-network oncology or those with established coverage at a network partner.

The practice does not suit patients without a confirmed diagnosis who need urgent staging or workup, those requiring inpatient chemotherapy or continuous infusion, patients needing simultaneous surgery or radiation planning, or those unable to travel to the practice location for bi-weekly to monthly appointments. Patients with very rare malignancies requiring molecular testing interpretation by a dedicated research lab may find better support at an academic cancer center.

What happens at the first visit

Arrive 15 minutes early with insurance card and photo ID. Bring all recent imaging (CT, MRI, PET), pathology reports, prior chemotherapy records, and a list of current medications. The oncologist will take a detailed treatment history, perform a physical examination, review pathology and imaging, discuss treatment options and their side effects, and outline a schedule. You will receive a written plan. If immediate infusion is planned, the nurse will place an IV or discuss port options. Most patients schedule their first chemotherapy for 1 to 2 weeks after consultation, allowing time for lab work, authorization, and scheduling.

Hours, location, and parking

Chesapeake Oncology Hematology Associates operates weekdays only. Specific address and parking details require confirmation directly with the practice (call for current location and lot availability). Most Baltimore oncology practices are in medical office parks with surface or structured parking; call ahead if you require accessible parking.

Chesapeake Oncology Hematology Associates fills a practical role for Baltimore oncology patients seeking stable, long-term outpatient care outside a large academic system, particularly those already diagnosed and treated elsewhere who value continuity and reduced appointment burden.